Pfizer hopes to benefit from that hype as it works feverishly on a weight loss pill it believes could be one of the ...
The same day Pfizer announced its portal, Lilly announced that it was making its popular weight loss drug Zepbound available in less-expensive vials that require the users to draw the drug ...
Pfizer, a multinational pharmaceutical and biotechnology corporation, is now a $159 billion (by market cap) healthcare giant.
Pfizer ( PFE) raised its full-year guidance by $1.5 billion and posted strong third quarter earnings Tuesday. The company now ...
Pfizer's anti-GDF-15 antibody ponsegromab was able to achieve weight gain ... programme for the drug next year. Cachexia is a complicated metabolic disorder that results in loss of muscle and ...
Meanwhile, Wall Street has a new fixation: diabetes and weight-loss drugs pioneered by Eli Lilly and Novo Nordisk. Pfizer has yet to distinguish itself in the increasingly competitive race for ...
Pfizer executives are still bullish on the opportunity for its own obesity and diabetes drugs under development, eyeing a potential opening for oral versions and an improved safet ...
It is a critical quarterly report for Pfizer, which is cutting costs as it works to recover from the rapid decline of its ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback